Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News International Stem Cell Corp ISCO

Healthcare Biotechnology
International Stem Cell Corporation is a clinical-stage biotechnology company that is focused on therapeutic and biomedical product development. The Company is primarily a research and development company, for the therapeutic market, which has focused on advancing potential clinical applications of human parthenogenetic stem cells (hpSCs) for the treatment of various diseases of the central... see more

Recent & Breaking News (OTCQB:ISCO)

International Stem Cell Corporation Announces Strong Financial Results for the Quarter Ended March 31, 2022

Accesswire May 17, 2022

International Stem Cell Corporation Announces 2021 Fourth Quarter and Year-End Results

Accesswire March 30, 2022

Small Pharma Strengthens Board With Appointment of Paul Maier as Independent Director

GlobeNewswire November 18, 2021

International Stem Cell Corporation Announces Successful Completion of Its Phase 1 Clinical Trial in Parkinson's Disease

Accesswire June 30, 2021

International Stem Cell Corporation Announces Financial Results for the Three and Nine-Months ended September 30, 2019

Accesswire November 15, 2019

International Stem Cell Corporation Announces Operating Results for the Quarter Ended March 31, 2019

GlobeNewswire May 17, 2019

International Stem Cell Corporation is Valued at $43 Million Market Value by Edison Investment Research

GlobeNewswire May 8, 2019

International Stem Cell Corporation Completes Enrollment and Dosing in its Parkinson's Disease Clinical Trial

GlobeNewswire April 29, 2019

International Stem Cell Corporation Announces 2018 Fourth Quarter and Year-End Results

GlobeNewswire April 15, 2019

OTC Markets Group Welcomes International Stem Cell Corporation to OTCQX

PR Newswire March 4, 2019

International Stem Cell Corporation Commences Trading on the OTCQX Best Market

GlobeNewswire March 4, 2019

International Stem Cell Corporation Publishes Successful Results in Traumatic Brain Injury

GlobeNewswire February 13, 2019

International Stem Cell Corporation Granted Key US Patent Protecting Anti-Aging Business

GlobeNewswire January 15, 2019

Edison issues update on International Stem Cell (ISCO)

GlobeNewswire December 4, 2018

International Stem Cell Corporation Announces Strong Financial Results for the Three and Nine-Months ended September 30, 2018

GlobeNewswire November 15, 2018

International Stem Cell Corporation to Present Clinical Data at the Society for Neuroscience Annual Meeting

GlobeNewswire October 30, 2018

International Stem Cell Corporation Doses Tenth Patient in Parkinson's Disease Clinical Trial

GlobeNewswire October 8, 2018

International Stem Cell Corporation Raised Funds Through a Private Placement at Premium to Market

GlobeNewswire October 2, 2018

International Stem Cell Corporation Granted Key US Patent Protecting Lead Therapeutic Program

GlobeNewswire August 21, 2018

International Stem Cell Corporation Announces Record Sales and Operating Results for the Three and Six-Months ended June 30, 2018

GlobeNewswire August 15, 2018